Marina Rodríguez Alonso

Veterinarian |MScs. Equine Physiotherapist | Brand & Product Leader Animal Health

The innovative radiofrequency technology developed by INDIBA has been causing ripples of excitement throughout the realm of equine medicine, offering groundbreaking solutions for an array of conditions. In a recent eBook, curated from the invaluable insights of esteemed professionals who not only contribute to the clinical reports but also serve as key figures in the INDIBA Official trainers’ program in the UK, the remarkable efficacy of INDIBA takes center stage. This program, spearheaded by the Animal Health Medical & Training department, plays a pivotal role in supporting users worldwide in harnessing the full potential of INDIBA in clinical applications.

Within the pages of this enlightening publication, a wealth of compelling case studies unfolds, each shedding light on the transformative impact of INDIBA in equine healthcare. From chronic ailments to acute injuries, these reports underscore the versatility and effectiveness of INDIBA across diverse scenarios. As we embark on a journey through these illuminating narratives, we gain deeper insights into the power of INDIBA to enhance the well-being and performance of our equine companions.

Here a summary of the case reports contained in the eBook:

1. Treatment of Lymphangitis with Radiofrequency  

Author: Faye Flood B.Sc.Hons;(CHIRO) M.I.V.C.A

• Successful outcome in a 7-year-old ISH: This case study showcases the successful management of lymphangitis in a 7-year-old Irish Sport Horse (ISH) using INDIBA over a 6-week period. The treatment not only improved circulation in the affected limb but also aided in the horse’s complete recovery, allowing it to return to eventing successfully.
• Chronic Lymphangitis Battle: A 12-year-old Thoroughbred stallion struggled with chronic lymphangitis for two years, serving as the catalyst for interest in INDIBA therapy. Despite long-term prednisone and antibiotic use, accompanied by red light therapy and massage, the stallion faced complications, including multi-drug resistance and a pathologic fracture of the hock. Despite intensive treatment efforts, the stallion did not recover, underscoring the severity and challenges associated with chronic cases.
• First Occurrence in a 3-Year-Old Mare: A 3-year-old ISH mare experienced her first bout of lymphangitis, presenting with significant swelling at the hock. Treatment commenced promptly, aiming to alleviate swelling and pain to facilitate breeding. Through a month of weekly INDIBA treatments, the mare exhibited notable improvement, becoming paddock sound and successfully bred from. Regrettably, the mare later succumbed to a field injury, highlighting the unpredictable nature of equine health.
• Successful Resolution in a 13-Year-Old Gelding: A 13-year-old ISH gelding was the first lymphangitis case treated with INDIBA therapy. Following a week of antibiotics and pain medication, two INDIBA sessions resulted in complete resolution of swelling. This success echoed in three mild cases, all responding positively to similar treatment approaches, indicating the potential efficacy of INDIBA in managing lymphangitis across varying severities.